American Well (AMWL) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

AMWL Stock Forecast


American Well stock forecast is as follows: an average price target of $8.40 (represents a -7.89% downside from AMWL’s last price of $9.12) and a rating consensus of 'Hold', based on 6 wall street analysts offering a 1-year stock forecast.

AMWL Price Target


The average price target for American Well (AMWL) is $8.40 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $5.00. This represents a potential -7.89% downside from AMWL's last price of $9.12.

AMWL Analyst Ratings


Hold

According to 6 Wall Street analysts, American Well's rating consensus is 'Hold'. The analyst rating breakdown for AMWL stock is 0 'Strong Buy' (0.00%), 2 'Buy' (33.33%), 4 'Hold' (66.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

American Well Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 06, 2023-Morgan Stanley$6.00$3.1888.68%-34.21%
Sep 07, 2022Jessica TassanPiper Sandler$5.00$4.3315.47%-45.18%
Dec 17, 2021Ricky GoldwasserMorgan Stanley$9.00$6.4339.97%-1.32%
Dec 01, 2021Glen SantangeloJefferies$6.00$6.22-3.54%-34.21%
Nov 12, 2021Kevin CaliendoUBS$10.00$8.6615.47%9.65%
Sep 14, 2021Steven HalperCantor Fitzgerald$15.00$10.3544.93%64.47%
Row per page
Go to

The latest American Well stock forecast, released on Jan 06, 2023 by Morgan Stanley company, set a price target of $6.00, which represents a 88.68% increase from the stock price at the time of the forecast ($3.18), and a -34.21% decrease from AMWL last price ($9.12).

American Well Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$9.12$9.12$9.12
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of American Well stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to American Well's last price of $9.12. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 24, 2024Cowen & Co.HoldHoldHold
Sep 24, 2024NeedhamHoldHoldHold
Aug 01, 2024Cowen & Co.HoldHoldHold
May 30, 2024Piper SandlerNeutralNeutralHold
Jan 06, 2023Morgan StanleyOverweightOverweightHold
Jan 04, 2023Bank of America Securities-BuyUpgrade
Jun 23, 2022Piper SandlerOverweightOverweightHold
Feb 28, 2022Wells FargoEqual-WeightEqual-WeightHold
May 14, 2021Piper SandlerOverweightOverweightHold
Row per page
Go to

American Well's last stock rating was published by Cowen & Co. on Sep 24, 2024. The company gave AMWL a "Hold" rating, the same as its previous rate.

American Well Financial Forecast


American Well Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue----------------$70.68M--$64.00M$79.23M$69.21M$64.52M$64.23M$72.75M$62.22M$60.22M$57.60M$60.43M$62.55M
Avg Forecast$105.60M$102.16M$98.93M$90.45M$97.42M$92.65M$89.60M$85.96M$87.54M$79.92M$78.93M$75.63M$71.07M$62.87M$61.57M$60.53M$70.16M$63.07M$65.87M$64.71M$78.08M$68.24M$64.13M$64.94M$68.95M$64.93M$61.51M$58.76M$54.55M$55.59M
High Forecast$113.07M$109.39M$105.93M$96.85M$104.32M$99.21M$95.94M$92.04M$93.74M$85.57M$84.52M$79.11M$76.40M$63.09M$61.57M$60.53M$71.29M$65.02M$70.53M$69.29M$83.61M$68.24M$64.13M$64.94M$68.95M$64.93M$61.51M$58.76M$54.55M$55.59M
Low Forecast$95.89M$92.77M$89.84M$82.14M$88.47M$84.13M$81.36M$78.06M$79.50M$72.57M$71.68M$73.66M$61.65M$62.64M$61.57M$60.53M$69.53M$59.88M$59.82M$58.76M$70.91M$68.24M$64.13M$64.94M$68.95M$64.93M$61.51M$58.76M$54.55M$55.59M
# Analysts44444444333563445115954475510755
Surprise %----------------1.01%--0.99%1.01%1.01%1.01%0.99%1.06%0.96%0.98%0.98%1.11%1.13%

American Well's average Quarter revenue forecast for Mar 24 based on 4 analysts is $60.53M, with a low forecast of $60.53M, and a high forecast of $60.53M. AMWL's average Quarter revenue forecast represents a -14.36% decrease compared to the company's last Quarter revenue of $70.68M (Dec 23).

American Well EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44444444333563445115954475510755
EBITDA----------------$-32.70M-$-83.14M$270.54M$-58.22M$-64.73M$-62.68M$-63.88M$-41.15M$-52.23M$-35.05M$-36.31M$-47.00M$-60.17M
Avg Forecast$-81.57M$-78.91M$-76.42M$-69.87M$-75.26M$-71.57M$-69.21M$-66.40M$-67.62M$-61.73M$-60.98M$-58.42M$-54.90M$-48.56M$-47.56M$-77.03M$-54.20M$-48.72M$-50.89M$-70.03M$-60.35M$-52.71M$-49.54M$-55.36M$-53.27M$-50.16M$-47.51M$-42.05M$-42.14M$-77.36M
High Forecast$-74.08M$-71.66M$-69.40M$-63.45M$-68.34M$-64.99M$-62.85M$-60.30M$-61.41M$-56.06M$-55.37M$-56.90M$-47.62M$-48.39M$-47.56M$-61.63M$-53.71M$-46.26M$-46.21M$-56.02M$-48.28M$-52.71M$-49.54M$-44.29M$-53.27M$-50.16M$-47.51M$-33.64M$-42.14M$-61.89M
Low Forecast$-87.35M$-84.50M$-81.83M$-74.81M$-80.59M$-76.63M$-74.11M$-71.10M$-72.41M$-66.10M$-65.29M$-61.11M$-59.02M$-48.74M$-47.56M$-92.44M$-55.07M$-50.23M$-54.49M$-84.04M$-72.43M$-52.71M$-49.54M$-66.43M$-53.27M$-50.16M$-47.51M$-50.45M$-42.14M$-92.84M
Surprise %----------------0.60%-1.63%-3.86%0.96%1.23%1.27%1.15%0.77%1.04%0.74%0.86%1.12%0.78%

5 analysts predict AMWL's average Quarter EBITDA for Jun 23 to be $-50.89M, with a high of $-46.21M and a low of $-54.49M. This is -118.81% lower than American Well's previous annual EBITDA (Mar 23) of $270.54M.

American Well Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44444444333563445115954475510755
Net Income----------------$-48.59M-$-92.47M$-397.86M$-60.67M$-69.98M$-69.10M$-70.04M$-46.87M$-51.49M$-37.86M$-39.19M$-50.31M$-63.08M
Avg Forecast$-7.57M$-8.17M$-9.84M$-12.56M$-14.17M$-14.84M$-14.97M$-17.36M$-28.45M$-30.18M$-31.62M$-33.52M$-45.10M$-51.56M$-60.33M$-84.74M$-59.89M$-63.34M$-67.78M$-77.04M$-70.10M$-76.91M$-77.83M$-60.90M$-81.31M$-70.56M$-57.47M$-45.38M$-67.48M$-81.10M
High Forecast$-6.66M$-7.20M$-8.66M$-11.06M$-12.48M$-13.07M$-13.18M$-15.29M$-25.05M$-26.57M$-27.84M$-29.81M$-36.41M$-45.40M$-53.12M$-67.80M$-56.74M$-54.30M$-59.68M$-61.63M$-56.08M$-76.91M$-77.83M$-48.72M$-81.31M$-70.56M$-57.47M$-36.30M$-67.48M$-64.88M
Low Forecast$-8.26M$-8.93M$-10.74M$-13.72M$-15.47M$-16.20M$-16.35M$-18.96M$-31.07M$-32.95M$-34.53M$-39.66M$-50.70M$-56.31M$-65.88M$-101.69M$-66.20M$-75.41M$-74.02M$-92.45M$-84.12M$-76.91M$-77.83M$-73.08M$-81.31M$-70.56M$-57.47M$-54.45M$-67.48M$-97.32M
Surprise %----------------0.81%-1.36%5.16%0.87%0.91%0.89%1.15%0.58%0.73%0.66%0.86%0.75%0.78%

American Well's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. AMWL's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

American Well SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44444444333563445115954475510755
SG&A----------------$46.19M-$57.87M$59.10M$64.30M$56.17M$53.63M$53.87M$35.94M$50.75M$39.00M$35.09M$42.83M$56.87M
Avg Forecast$81.33M$78.68M$76.19M$69.66M$75.04M$71.36M$69.01M$66.20M$67.42M$61.55M$60.80M$58.25M$54.74M$48.42M$47.42M$46.62M$54.04M$48.58M$50.73M$59.26M$52.71M$52.55M$49.39M$46.84M$53.11M$50.01M$47.37M$40.63M$42.02M$42.82M
High Forecast$87.09M$84.25M$81.59M$74.59M$80.35M$76.41M$73.89M$70.89M$72.20M$65.91M$65.10M$60.93M$58.84M$48.59M$47.42M$46.62M$54.90M$50.08M$54.33M$71.11M$63.26M$52.55M$49.39M$56.21M$53.11M$50.01M$47.37M$48.75M$42.02M$42.82M
Low Forecast$73.86M$71.45M$69.19M$63.26M$68.14M$64.80M$62.67M$60.12M$61.23M$55.90M$55.21M$56.73M$47.48M$48.25M$47.42M$46.62M$53.55M$46.12M$46.07M$47.41M$42.17M$52.55M$49.39M$37.47M$53.11M$50.01M$47.37M$32.50M$42.02M$42.82M
Surprise %----------------0.85%-1.14%1.00%1.22%1.07%1.09%1.15%0.68%1.01%0.82%0.86%1.02%1.33%

American Well's average Quarter SG&A projection for Mar 24 is $46.62M, based on 4 Wall Street analysts, with a range of $46.62M to $46.62M. The forecast indicates a 0.94% rise compared to AMWL last annual SG&A of $46.19M (Dec 23).

American Well EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts44444444333563445115954475510755
EPS----------------$-0.00-$-0.33$-1.42$-0.22$-0.25$-0.25$-0.26$-0.18$-0.20$-0.15$-0.16$-0.21$-0.92
Avg Forecast$-0.50$-0.54$-0.65$-0.83$-0.94$-0.98$-0.99$-1.15$-1.88$-1.99$-2.09$-2.21$-2.98$-3.41$-3.99$-4.00$-3.96$-4.19$-4.48$-4.23$-5.10$-5.17$-5.23$-4.77$-5.47$-4.74$-3.86$-3.83$-4.54$-5.85
High Forecast$-0.44$-0.48$-0.57$-0.73$-0.82$-0.86$-0.87$-1.01$-1.66$-1.76$-1.84$-1.97$-2.41$-3.00$-3.51$-3.52$-3.75$-3.59$-3.94$-3.72$-4.50$-5.17$-5.23$-4.77$-5.47$-4.74$-3.86$-3.83$-4.54$-5.85
Low Forecast$-0.55$-0.59$-0.71$-0.91$-1.02$-1.07$-1.08$-1.25$-2.05$-2.18$-2.28$-2.62$-3.35$-3.72$-4.35$-4.36$-4.37$-4.98$-4.89$-4.62$-5.57$-5.17$-5.23$-4.77$-5.47$-4.74$-3.86$-3.83$-4.54$-5.85
Surprise %----------------0.00%-0.07%0.34%0.04%0.05%0.05%0.05%0.03%0.04%0.04%0.04%0.05%0.16%

According to undefined Wall Street analysts, American Well's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to AMWL previous annual EPS of $NaN (undefined).

American Well Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
TDOCTeladoc Health$8.87$50.87473.51%Hold
HCATHealth Catalyst$7.68$29.25280.86%Buy
GDRXGoodRx$5.87$14.57148.21%Buy
DHDefinitive Healthcare$4.08$9.50132.84%Hold
CERTCertara$10.25$20.60100.98%Buy
PHRPhreesia$18.46$36.3196.70%Buy
PGNYProgyny$15.15$29.0091.42%Hold
TXG10x Genomics$16.78$30.2079.98%Hold
PRVAPrivia Health Group$19.22$33.8275.96%Buy
SDGRSchrödinger$18.24$28.6757.18%Buy
VEEVVeeva Systems$212.53$229.718.08%Buy
GEHCGE HealthCare$86.99$93.407.37%Buy
DOCSDoximity$41.82$39.29-6.05%Buy
AMWLAmerican Well$9.12$8.40-7.89%Hold

AMWL Forecast FAQ


No, according to 6 Wall Street analysts, American Well (AMWL) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 33.33% of AMWL's total ratings.

American Well (AMWL) average price target is $8.4 with a range of $5 to $15, implying a -7.89% from its last price of $9.12. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for AMWL stock, the company can go down by -7.89% (from the last price of $9.12 to the average price target of $8.4), up by 64.47% based on the highest stock price target, and down by -45.18% based on the lowest stock price target.

AMWL's highest twelve months analyst stock price target of $15 supports the claim that American Well can reach $14 in the near future.

American Well's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $365.62M (high $391.5M, low $332.03M), average EBITDA is $-282M (high $-256M, low $-302M), average net income is $-61.342M (high $-54.014M, low $-66.986M), average SG&A $281.6M (high $301.53M, low $255.73M), and average EPS is $-4.053 (high $-3.569, low $-4.426). AMWL's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $397.13M (high $425.24M, low $360.64M), average EBITDA is $-307M (high $-279M, low $-328M), average net income is $-38.141M (high $-33.585M, low $-41.651M), average SG&A $305.87M (high $327.52M, low $277.76M), and average EPS is $-2.52 (high $-2.219, low $-2.752).

Based on American Well's last annual report (Dec 2022), the company's revenue was $277.19M, beating the average analysts forecast of $275.39M by 0.65%. Apple's EBITDA was $-250M, beating the average prediction of $-218M by 14.56%. The company's net income was $-270M, missing the average estimation of $-286M by -5.58%. Apple's SG&A was $227.98M, beating the average forecast of $201.5M by 13.14%. Lastly, the company's EPS was $-0.98, missing the average prediction of $-20.276 by -95.17%. In terms of the last quarterly report (Dec 2023), American Well's revenue was $70.68M, beating the average analysts' forecast of $70.16M by 0.73%. The company's EBITDA was $-32.697M, missing the average prediction of $-54.2M by -39.67%. American Well's net income was $-48.587M, missing the average estimation of $-59.891M by -18.87%. The company's SG&A was $46.19M, missing the average forecast of $54.04M by -14.53%. Lastly, the company's EPS was $-0.0002, missing the average prediction of $-3.957 by -99.99%